Salesforce reported its Q3 results on September 16, and the stock's 30% one-month rally has drawn a swift and notable response from short sellers — even as the options market and the analyst community both turned more constructive in the wake of the print.
The clearest post-earnings signal is the short rebuild. Short interest jumped 21% on the week to 29 million shares, now 3.0% of the free float — a sharp reversal from the aggressive covering that ran through August and into early September. At the trough, shorts had retreated to roughly 23.6 million shares around September 9. The two-day spike of more than 5 million shares through September 14–15 is the fastest rebuild in the 30-day window and marks the highest short count since late August. The previous earnings note flagged that bears had been covering hard into the print; they are now re-entering just as quickly. That said, the borrow market is sending no distress signals — cost to borrow is negligible at 0.44%, and availability is exceptionally loose at nearly 5,900%, far above the 52-week floor of 309%. There is ample supply for any short seller who wants in.
Options positioning also shifted after earnings, though less dramatically than the short interest move. The put/call ratio eased marginally to 1.02 — still above its 20-day mean of 0.96 and near the 52-week high of 1.05. The z-score of 0.85 means the PCR is running about one standard deviation defensive, but it has not pushed into extreme hedging territory. What's notable is the contrast with late August: through most of that month, the PCR sat in the low 0.82 range, and the steady drift upward toward put-call parity through the earnings run-up was flagged in the prior note. Post-print, the ratio has held near its elevated level rather than collapsing — suggesting options traders are not rushing to rip off downside protection despite the stock's strong performance. The borrow and options signals together paint a picture of a market that is cautious but not crowded.
The Street, by contrast, is clearly more enthusiastic. Analysts moved swiftly after the Q3 print. Mizuho raised its target to $280 from $265 this morning, reiterating Outperform. Stifel held at $275 with a Buy. Earlier post-earnings, JPMorgan's Mark Murphy lifted to $265 from $250, TD Cowen moved to $300, and Cantor Fitzgerald raised to $300 from $250. The mean consensus target now sits at $275.87, roughly 8% above the current price of $255.65. The outlier is Needham, which maintained a $400 target — well above the pack and a figure to treat with caution given the divergence from consensus. On the cautious side, Citigroup raised to $233 from $204 while keeping Neutral, placing its target below the current share price. The analyst split is therefore not bull-vs-bear so much as degree-of-conviction bull vs. selective cautious: the Neutral camp is upgrading its view of fair value, just not rushing to chase a 30% move. Factor scores confirm the earnings-revision story: EPS momentum over 30 days ranks in the 93rd percentile, a top-decile reading that reflects the magnitude of estimate upgrades following the print.
The ownership picture adds some texture. The recent insider log is thin on meaningful signal. Director Craig Conway sold just under $1.2 million in open-market shares on September 4 — modest relative to Salesforce's scale and carrying no 10b5-1 plan designation, though the significance scores are low. The August 22 cluster of director option exercises and tax-withholding sales are routine compensation mechanics. The net 90-day insider position is a small negative at roughly -$1.2 million, not a directional conviction trade in either direction. On the institutional side, BlackRock added 1 million shares through August and State Street added 873,000 — incremental flows consistent with passive rebalancing into a rallying stock rather than an active conviction shift. Morgan Stanley, notably, trimmed by 7.7 million shares as of June 30, though that predates the August earnings catalyst. The previous note highlighted that the earnings history showed a massive 22.5% next-day move on the August 26 print — and the stock has followed through, now up 30% on the month as that move was absorbed and extended.
The last prior earnings print delivered a +22.5% one-day move and +24.9% over five days. With the stock now trading at $255.65, the key question is whether the short rebuild proves prescient — or whether it becomes fuel for another leg higher. The ORTEX short score at 33.8 remains moderate, up only slightly on the week, and peer names like NOW gained 5.7% and APPN rose 9.7% on the week, suggesting the enterprise software tape has been broadly constructive. What to watch: whether the short interest build accelerates through next week as more bears reset positions, and whether the PCR retreats toward its August lows as hedges are unwound — or whether both stay elevated, signalling that the market sees the post-earnings pop as a selling opportunity rather than a new base.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
